Eszopiclone Tablet, Film Coated
Product Images NDC 71335-2002

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Eszopiclone (NDC 71335-2002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eszopiclone-chemical-structure (Eszopiclone Chemical Structure)

Eszopiclone-chemical-structure (Eszopiclone Chemical Structure)
Chemical structure of Eszopiclone showing the molecular arrangement, including rings with nitrogen atoms, a chlorine substituent, and other functional groups consistent with this active pharmaceutical ingredient.*
FDA Label Image
FDA Label Image

Label (Lbl713352002)

Label (Lbl713352002)
Label for Eszopiclone 3 mg (CIV) film-coated tablet by Bryant Ranch Prepack. The package states it is RX only and includes storage instructions at 20°-25°C (68°-77°F). The label references comparison to Lunesta 3 mg (CIV) tablets and lists a quantity of 30 tablets. The NDC number 71335-2002-1 is shown along with a barcode and a caution that the drug may cause drowsiness.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.